Autologous Stem Cell Transplantation for Adult Acute Myelocytic Leukemia in First Remission-Better Outcomes After Busulfan and Melphalan Compared With Busulfan and Cyclophosphamide: A Retrospective Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

NC Gorin; M Labopin; T Czerw; T Pabst; D Blaise; PY Dumas; D Nemet; W Arcese; SM Trisolini; D P Wu; A Huynh; T Zuckerman; E Meijer; S Cagirgan; Jan Cornelissen; M Houhou; E Polge; M Mohty; A Nagler

doi:10.1002/cncr.30400

Autologous Stem Cell Transplantation for Adult Acute Myelocytic Leukemia in First Remission-Better Outcomes After Busulfan and Melphalan Compared With Busulfan and Cyclophosphamide: A Retrospective Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

NC Gorin, M Labopin, T Czerw, T Pabst, D Blaise, PY Dumas, D Nemet, W Arcese, SM Trisolini, D P Wu, A Huynh, T Zuckerman, E Meijer, S Cagirgan, Jan Cornelissen, M Houhou, E Polge, M Mohty, A Nagler

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

30 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	824-831
Number of pages	8
Journal	Cancer
Volume	123
Issue number	5
DOIs	https://doi.org/10.1002/cncr.30400
Publication status	Published - 2017

Research programs

EMC OR-01

Access to Document

10.1002/cncr.30400

http://hdl.handle.net/1765/94989

Cite this

Gorin, NC., Labopin, M., Czerw, T., Pabst, T., Blaise, D., Dumas, PY., Nemet, D., Arcese, W., Trisolini, SM., Wu, D. P., Huynh, A., Zuckerman, T., Meijer, E., Cagirgan, S., Cornelissen, J., Houhou, M., Polge, E., Mohty, M., & Nagler, A. (2017). Autologous Stem Cell Transplantation for Adult Acute Myelocytic Leukemia in First Remission-Better Outcomes After Busulfan and Melphalan Compared With Busulfan and Cyclophosphamide: A Retrospective Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Cancer, 123(5), 824-831. https://doi.org/10.1002/cncr.30400

Gorin, NC ; Labopin, M ; Czerw, T et al. / Autologous Stem Cell Transplantation for Adult Acute Myelocytic Leukemia in First Remission-Better Outcomes After Busulfan and Melphalan Compared With Busulfan and Cyclophosphamide: A Retrospective Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). In: Cancer. 2017 ; Vol. 123, No. 5. pp. 824-831.

@article{ca9cc5b782f04704b417877ef35f656e,

title = "Autologous Stem Cell Transplantation for Adult Acute Myelocytic Leukemia in First Remission-Better Outcomes After Busulfan and Melphalan Compared With Busulfan and Cyclophosphamide: A Retrospective Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)",

author = "NC Gorin and M Labopin and T Czerw and T Pabst and D Blaise and PY Dumas and D Nemet and W Arcese and SM Trisolini and Wu, {D P} and A Huynh and T Zuckerman and E Meijer and S Cagirgan and Jan Cornelissen and M Houhou and E Polge and M Mohty and A Nagler",

year = "2017",

doi = "10.1002/cncr.30400",

language = "Undefined/Unknown",

volume = "123",

pages = "824--831",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley & Sons Inc.",

number = "5",

}

Gorin, NC, Labopin, M, Czerw, T, Pabst, T, Blaise, D, Dumas, PY, Nemet, D, Arcese, W, Trisolini, SM, Wu, DP, Huynh, A, Zuckerman, T, Meijer, E, Cagirgan, S, Cornelissen, J, Houhou, M, Polge, E, Mohty, M & Nagler, A 2017, 'Autologous Stem Cell Transplantation for Adult Acute Myelocytic Leukemia in First Remission-Better Outcomes After Busulfan and Melphalan Compared With Busulfan and Cyclophosphamide: A Retrospective Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)', Cancer, vol. 123, no. 5, pp. 824-831. https://doi.org/10.1002/cncr.30400

Autologous Stem Cell Transplantation for Adult Acute Myelocytic Leukemia in First Remission-Better Outcomes After Busulfan and Melphalan Compared With Busulfan and Cyclophosphamide: A Retrospective Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). / Gorin, NC; Labopin, M; Czerw, T et al.
In: Cancer, Vol. 123, No. 5, 2017, p. 824-831.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Autologous Stem Cell Transplantation for Adult Acute Myelocytic Leukemia in First Remission-Better Outcomes After Busulfan and Melphalan Compared With Busulfan and Cyclophosphamide: A Retrospective Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

AU - Gorin, NC

AU - Labopin, M

AU - Czerw, T

AU - Pabst, T

AU - Blaise, D

AU - Dumas, PY

AU - Nemet, D

AU - Arcese, W

AU - Trisolini, SM

AU - Wu, D P

AU - Huynh, A

AU - Zuckerman, T

AU - Meijer, E

AU - Cagirgan, S

AU - Cornelissen, Jan

AU - Houhou, M

AU - Polge, E

AU - Mohty, M

AU - Nagler, A

PY - 2017

Y1 - 2017

U2 - 10.1002/cncr.30400

DO - 10.1002/cncr.30400

M3 - Article

C2 - 27906458

SN - 0008-543X

VL - 123

SP - 824

EP - 831

JO - Cancer

JF - Cancer

IS - 5

ER -

Gorin NC, Labopin M, Czerw T, Pabst T, Blaise D, Dumas PY et al. Autologous Stem Cell Transplantation for Adult Acute Myelocytic Leukemia in First Remission-Better Outcomes After Busulfan and Melphalan Compared With Busulfan and Cyclophosphamide: A Retrospective Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Cancer. 2017;123(5):824-831. doi: 10.1002/cncr.30400